CORRECTING and REPLACING Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021Business Wire • 02/23/21
Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021Business Wire • 02/11/21
Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources OfficerBusiness Wire • 02/08/21
Personalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceBusiness Wire • 02/04/21
Personalis Announces the Launch of NEOPS™, a Neoantigen-based Composite Biomarker for Cancer Immunotherapy ResponseBusiness Wire • 12/17/20
Personalis Announces Delivery of the 100,000th Genome to the U.S. Department of Veterans Affairs Million Veteran ProgramBusiness Wire • 12/09/20
Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual MeetingBusiness Wire • 11/09/20
Personalis' (PSNL) CEO John West on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
Personalis to Announce Third Quarter 2020 Financial Results on November 5, 2020Business Wire • 10/22/20
Personalis Receives Contract Extension and New Task Order From the VA’s Million Veteran Program – Total Awarded to Date Now $175MBusiness Wire • 09/17/20
Personalis Strengthens Commercial Team with the Appointment of New Head of Population GenomicsBusiness Wire • 09/15/20